首鋼資源(00639.HK)2024年擁有人應佔溢利14.94億港元 按年下跌約21%
格隆匯3月27日丨首鋼資源(00639.HK)公告,截至2024年12月31日止年度,集團錄得營業收益約50.57億港元,較去年度約58.91億港元按年減少約8.34億港元或14%。集團錄得淨利潤約18.15億港元,以及公司擁有人應佔溢利約14.94億港元,按年均下跌約21%。每股基本盈利爲30.12港仙(2023年度:37.55港仙(經重列))按年下跌約20%,與擁有人應佔溢利按年減少約21%相若。
營業收益下跌主要因爲回顧年度精焦煤的平均實現售價按年下調14%,連同平均人民幣兌港元匯率按年下調約1.2%的負面影響,抵銷了精焦煤銷量按年微升約1%正面影響所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.